190 related articles for article (PubMed ID: 37349325)
21. Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations.
Lal A; Ramazzotti D; Weng Z; Liu K; Ford JM; Sidow A
BMC Med Genomics; 2019 Jun; 12(1):84. PubMed ID: 31182087
[TBL] [Abstract][Full Text] [Related]
22. Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma.
Cheng C; Zhou Y; Li H; Xiong T; Li S; Bi Y; Kong P; Wang F; Cui H; Li Y; Fang X; Yan T; Li Y; Wang J; Yang B; Zhang L; Jia Z; Song B; Hu X; Yang J; Qiu H; Zhang G; Liu J; Xu E; Shi R; Zhang Y; Liu H; He C; Zhao Z; Qian Y; Rong R; Han Z; Zhang Y; Luo W; Wang J; Peng S; Yang X; Li X; Li L; Fang H; Liu X; Ma L; Chen Y; Guo S; Chen X; Xi Y; Li G; Liang J; Yang X; Guo J; Jia J; Li Q; Cheng X; Zhan Q; Cui Y
Am J Hum Genet; 2016 Feb; 98(2):256-74. PubMed ID: 26833333
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women.
Filippova OT; Selenica P; Pareja F; Vahdatinia M; Zhu Y; Pei X; Riaz N; Long Roche K; Chi DS; Abu-Rustum NR; Ellenson LH; Reis-Filho JS; Zamarin D; Weigelt B
Gynecol Oncol; 2021 May; 161(2):545-552. PubMed ID: 33674143
[TBL] [Abstract][Full Text] [Related]
24. Driver Gene Alterations in Malignant Progression of Gastric Cancer.
Dong Y; Song N; Wang J; Shi L; Zhang Z; Du J
Front Oncol; 2022; 12():920207. PubMed ID: 35903675
[TBL] [Abstract][Full Text] [Related]
25. DNA Methylation and Genetic Aberrations in Gastric Cancer.
Usui G; Matsusaka K; Mano Y; Urabe M; Funata S; Fukayama M; Ushiku T; Kaneda A
Digestion; 2021; 102(1):25-32. PubMed ID: 33070127
[TBL] [Abstract][Full Text] [Related]
26. Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.
Qiu Y; Zhang ZY; Du WD; Ye L; Xu S; Zuo XB; Zhou FS; Chen G; Ma XL; Schneider ME; Xia HZ; Zhou Y; Wu JF; Yuan-Hong X; Zhang XJ
Gene; 2014 Feb; 535(2):225-32. PubMed ID: 24291029
[TBL] [Abstract][Full Text] [Related]
27. Allele-Specific Quantification of Structural Variations in Cancer Genomes.
Li Y; Zhou S; Schwartz DC; Ma J
Cell Syst; 2016 Jul; 3(1):21-34. PubMed ID: 27453446
[TBL] [Abstract][Full Text] [Related]
28. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients.
Kim ST; Banks KC; Pectasides E; Kim SY; Kim K; Lanman RB; Talasaz A; An J; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Park SH; Park JO; Park YS; Lim HY; Kim NKD; Park W; Lee H; Bass AJ; Kim K; Kang WK; Lee J
Ann Oncol; 2018 Apr; 29(4):1037-1048. PubMed ID: 29409051
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes.
Hillmer AM; Yao F; Inaki K; Lee WH; Ariyaratne PN; Teo AS; Woo XY; Zhang Z; Zhao H; Ukil L; Chen JP; Zhu F; So JB; Salto-Tellez M; Poh WT; Zawack KF; Nagarajan N; Gao S; Li G; Kumar V; Lim HP; Sia YY; Chan CS; Leong ST; Neo SC; Choi PS; Thoreau H; Tan PB; Shahab A; Ruan X; Bergh J; Hall P; Cacheux-Rataboul V; Wei CL; Yeoh KG; Sung WK; Bourque G; Liu ET; Ruan Y
Genome Res; 2011 May; 21(5):665-75. PubMed ID: 21467267
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
Carraro DM; Koike Folgueira MA; Garcia Lisboa BC; Ribeiro Olivieri EH; Vitorino Krepischi AC; de Carvalho AF; de Carvalho Mota LD; Puga RD; do Socorro Maciel M; Michelli RA; de Lyra EC; Grosso SH; Soares FA; Achatz MI; Brentani H; Moreira-Filho CA; Brentani MM
PLoS One; 2013; 8(3):e57581. PubMed ID: 23469205
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy.
Huh YJ; Cho SY; Cho MS; Lee KE; Lee JH
Genes Genomics; 2022 Nov; 44(11):1425-1435. PubMed ID: 35622232
[TBL] [Abstract][Full Text] [Related]
32. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y
Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121
[TBL] [Abstract][Full Text] [Related]
33. Mutations of key driver genes in gastric cancer metastasis risk: a systematic review and meta-analysis.
Wang J; Shao X; Liu Y; Shi R; Yang B; Xiao J; Liu Y; Qu X; Li Z
Expert Rev Mol Diagn; 2021 Sep; 21(9):963-972. PubMed ID: 34196586
[No Abstract] [Full Text] [Related]
34. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
Chen K; Yang D; Li X; Sun B; Song F; Cao W; Brat DJ; Gao Z; Li H; Liang H; Zhao Y; Zheng H; Li M; Buckner J; Patterson SD; Ye X; Reinhard C; Bhathena A; Joshi D; Mischel PS; Croce CM; Wang YM; Raghavakaimal S; Li H; Lu X; Pan Y; Chang H; Ba S; Luo L; Cavenee WK; Zhang W; Hao X
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1107-12. PubMed ID: 25583476
[TBL] [Abstract][Full Text] [Related]
35. Profiling of gene fusion involving targetable genes in Chinese gastric cancer.
Liu ZH; Zhu BW; Shi M; Qu YR; He XJ; Yuan HL; Ma J; Li W; Zhao DD; Liu ZC; Wang BM; Wang CY; Tao HQ; Ma TH
World J Gastrointest Oncol; 2022 Aug; 14(8):1528-1539. PubMed ID: 36160735
[TBL] [Abstract][Full Text] [Related]
36. Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization.
Tajiri R; Ooi A; Fujimura T; Dobashi Y; Oyama T; Nakamura R; Ikeda H
Hum Pathol; 2014 Apr; 45(4):725-34. PubMed ID: 24491355
[TBL] [Abstract][Full Text] [Related]
37. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.
Asaoka Y; Tada M; Ikenoue T; Seto M; Imai M; Miyabayashi K; Yamamoto K; Yamamoto S; Kudo Y; Mohri D; Isomura Y; Ijichi H; Tateishi K; Kanai F; Ogawa S; Omata M; Koike K
Biochem Biophys Res Commun; 2010 Apr; 394(4):1042-6. PubMed ID: 20331976
[TBL] [Abstract][Full Text] [Related]
38. Clonal Structures of Regionally Synchronous Gastric Adenomas and Carcinomas.
Jung SH; Kim SY; An CH; Lee SH; Jung ES; Park HC; Kim MS; Chung YJ; Lee SH
Clin Cancer Res; 2018 Oct; 24(19):4715-4725. PubMed ID: 29945994
[No Abstract] [Full Text] [Related]
39. Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer.
Tamilzhalagan S; Muthuswami M; Periasamy J; Lee MH; Rha SY; Tan P; Ganesan K
Cell Signal; 2015 Jun; 27(6):1075-86. PubMed ID: 25697906
[TBL] [Abstract][Full Text] [Related]
40.
Warner E; Herberts C; Fu S; Yip S; Wong A; Wang G; Ritch E; Murtha AJ; Vandekerkhove G; Fonseca NM; Angeles A; Beigi A; Schönlau E; Beja K; Annala M; Khalaf D; Chi KN; Wyatt AW
Clin Cancer Res; 2021 Mar; 27(6):1650-1662. PubMed ID: 33414135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
